文献速递膀胱癌与上尿路尿路上皮癌

血尿诊断评估的差异:性别、种族与膀胱癌危险因素的影响

Variation in the Diagnostic Evaluation among Persons with Hematuria: Influence of Gender, Race and Risk Factors for Bladder Cancer.
PubMed 文献 · J Urol · 2017-06-24

研究利用SCCS与Medicare理赔数据,分析1412例新发血尿患者,仅261例(18%)在180天内完成影像与膀胱镜检查。校正分析显示,非裔美国人较白人更少接受任何评估环节,女性较男性更少转诊泌尿科,2或3个危险因素仅与男性转诊几率升高相关。

要点

  • 新发血尿患者中仅18%在180天内完成影像与膀胱镜检查。
  • 非裔美国人较白人更少接受泌尿科转诊、膀胱镜和影像评估。
  • 女性较男性更少转诊泌尿科;危险因素数量仅预测男性转诊。

核心结论

  • 仅18%的新发血尿患者接受了完整的血尿评估。
  • 在校正社会经济因素后,性别对泌尿科转诊有实质性影响,但对评估质量的作用不明确。
  • 非裔美国人接受全面评估的比率显著低于白人。
  • 危险因素数量可预测男性泌尿科转诊,但对评估的预测作用不佳。
  • 作者认为存在改善血尿评估完成率的机会,尤其在高危和脆弱患者中。

研究设计与样本

  • 利用SCCS自我报告数据与Medicare理赔数据链接的观察性研究。
  • 共纳入1412例新发血尿诊断患者。
  • 评估完整性定义为诊断后180天内完成影像和膀胱镜检查。
  • 暴露因素为种族、性别和膀胱癌危险因素。

主要发现

  • 1412例患者中评估完整者261例(18%)。
  • 校正分析中,非裔美国人较白人更少接受泌尿科转诊(OR 0.72,95%CI 0.56-0.93)。
  • 非裔美国人较白人更少接受膀胱镜检查(OR 0.67,95%CI 0.50-0.89)。
  • 非裔美国人较白人更少接受影像检查(OR 0.75,95%CI 0.59-0.95)。
  • 女性较男性更少转诊泌尿科(OR 0.59,95%CI 0.46-0.76)。

关键数值与推荐

  • 评估完整定义为诊断后180天内完成影像和膀胱镜检查。
  • 非裔美国人vs白人:泌尿科转诊OR 0.72(95%CI 0.56-0.93),膀胱镜OR 0.67(95%CI 0.50-0.89),影像OR 0.75(95%CI 0.59-0.95)。
  • 女性vs男性:泌尿科转诊OR 0.59(95%CI 0.46-0.76)。
  • 2或3个危险因素vs其他:泌尿科转诊OR 1.31(95%CI 1.02-1.69),效应仅见于男性。

临床怎么用

  • 作者认为存在改善血尿评估完成率的机会,尤其在高危和脆弱患者中。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to determine whether race, gender and number of bladder cancer risk factors are significant predictors of hematuria evaluation. MATERIALS AND METHODS: We used self-reported data from SCCS (Southern Community Cohort Study) linked to Medicare claims data. Evaluation of subjects diagnosed with incident hematuria was considered complete if imaging and cystoscopy were performed within 180 days of diagnosis. Exposures of interest were race, gender and risk factors for bladder cancer. RESULTS: Of the 1,412 patients evaluation was complete in 261 (18%). On our adjusted analyses African American patients were less likely than Caucasian patients to undergo any aspect of evaluation, including urology referral (OR 0.72, 95% CI 0.56-0.93), cystoscopy (OR 0.67, 95% CI 0.50-0.89) and imaging (OR 0.75, 95% CI 0.59-0.95). Women were less likely than men to be referred to a urologist (OR 0.59, 95% CI 0.46-0.76). Also, although all patients with 2 or 3 risk factors had 31% higher odds of urology referral (OR 1.31, 95% CI 1.02-1.69), adjusted analyses indicated that this effect was only apparent among men. CONCLUSIONS: Only 18% of patients with an incident hematuria diagnosis underwent complete hematuria evaluation. Gender had a substantial effect on referral to urology when controlling for socioeconomic factors but otherwise it had an unclear role on the quality of evaluation. African American patients had markedly lower rates of thorough evaluation than Caucasian patients. Number of risk factors predicted referral to urology among men but it was otherwise a poor predictor of evaluation. There is opportunity for improvement by increasing the completion of hematuria evaluations, particularly in patients at high risk and those who are vulnerable.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Ark JT, Alvarez JR, Koyama T, et al. Variation in the Diagnostic Evaluation among Persons with Hematuria: Influence of Gender, Race and Risk Factors for Bladder Cancer. J Urol. 2017. PMID: 28655530. doi:10.1016/j.juro.2017.06.083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。